TY  - GEN
AU  - Saydam,Faruk
AU  - Değirmenci,İrfan
AU  - Birdane,Alparslan
AU  - Özdemir,Mahmut
AU  - Ulus,Taner
AU  - Özbayer,Cansu
AU  - Çolak,Ertuğrul
AU  - Ata,Necmi
AU  - Güneş,Hasan Veysi
TI  - The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study
SN  - 1742-7843
PY  - 2018///0403
KW  - Aged
KW  - Aspirin
KW  - pharmacology
KW  - Clopidogrel
KW  - Coronary Artery Disease
KW  - surgery
KW  - Cytochrome P-450 CYP2C19
KW  - genetics
KW  - Female
KW  - Gene Frequency
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myocardial Ischemia
KW  - etiology
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Platelet Activation
KW  - drug effects
KW  - Platelet Aggregation
KW  - Platelet Aggregation Inhibitors
KW  - Polymorphism, Single Nucleotide
KW  - Postoperative Complications
KW  - Sequence Analysis, DNA
KW  - Stents
KW  - Thrombosis
KW  - Ticlopidine
KW  - analogs & derivatives
KW  - Treatment Outcome
KW  - Turkey
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/bcpt.12763
ER  -